Author:
Wan Wei-Li,He Yun,Guan Mei,Li Xiao-Long,Cheng Xu,Wu Yong
Reference11 articles.
1. Practical asymmetric synthesis of Aprepitant, a potent human NK-1 receptor antagonist, via a stereoselective Lewis acid-catalyzed trans acetalization reaction;Zhao;J. Org. Chem.,2002
2. Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study
3. NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011;Miguel;Expert Opin. Ther. Patents,2012
4. Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant;Shreerang;PCT Int. Appl.,2012
5. An alternative approach to achieve enantiopure (3S)-4-benzyl-3-(4-fluorophenyl)morpholin-2-one: a key intermediate of Aprepitant, an NK1 receptor antagonist;Kolla;Org. Process Res. Dev.,2007
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献